Peptide fragments of conservative sites of PorA, OpaB, and NspA proteins of the outer membrane of serogroup B meningococci were synthesized. These peptides caused a pronounced protective effect in immunized mice infected with virulent homologous and heterologous strains of serogroups B and A meningococci. The protective effect appreciably increased, if the studied peptides were associated in a polycomponent preparation, which can be used in the construction of meningococcal bivalent B+A vaccine. © Springer Science+Business Media, Inc. 2005
A variety of adjuvants with the potential for use with experimental human vaccines were used for imm...
Microbial capsular polysaccharides for many years provided a highly practical public health vaccines...
The antigenic similarity between Neisseria meningitidis group B (NMGB) capsular polysaccharide (PS) ...
Peptide fragments of conservative sites of PorA, OpaB, and NspA proteins of the outer membrane of se...
Immunization of mice with synthetic peptide fragments of conservative sites of meningococcal outer m...
Four potentially immunoactive peptide fragments of the NspA protein from the outer membrane of the N...
Four potentially immunoactive peptide fragments of the NspA protein from the outer membrane of the b...
Fourteen peptides corresponding to sequences of all the exposed and some of the transmembrane protei...
Fourteen peptides corresponding to sequences of all the exposed and some of the transmembrane protei...
Mice of various lines were immunized by 11 synthetic peptides that correspond to the sequences of fr...
Mice of various lines were immunized by 11 synthetic peptides that correspond to the sequences of fr...
A new approach to the development of a vaccine against meningococci of serogroups A and B was propos...
The class 1 outer-membrane protein of Neisseria meningitidis is the target for subtype-specific, bac...
Use of the serogroup B meningococcal capsular polysaccharide (MenB CP) as a vaccine is hampered by t...
Previous analysis of the class 1 outer-membrane (OM) protein of Neisseria meningitidis has identifie...
A variety of adjuvants with the potential for use with experimental human vaccines were used for imm...
Microbial capsular polysaccharides for many years provided a highly practical public health vaccines...
The antigenic similarity between Neisseria meningitidis group B (NMGB) capsular polysaccharide (PS) ...
Peptide fragments of conservative sites of PorA, OpaB, and NspA proteins of the outer membrane of se...
Immunization of mice with synthetic peptide fragments of conservative sites of meningococcal outer m...
Four potentially immunoactive peptide fragments of the NspA protein from the outer membrane of the N...
Four potentially immunoactive peptide fragments of the NspA protein from the outer membrane of the b...
Fourteen peptides corresponding to sequences of all the exposed and some of the transmembrane protei...
Fourteen peptides corresponding to sequences of all the exposed and some of the transmembrane protei...
Mice of various lines were immunized by 11 synthetic peptides that correspond to the sequences of fr...
Mice of various lines were immunized by 11 synthetic peptides that correspond to the sequences of fr...
A new approach to the development of a vaccine against meningococci of serogroups A and B was propos...
The class 1 outer-membrane protein of Neisseria meningitidis is the target for subtype-specific, bac...
Use of the serogroup B meningococcal capsular polysaccharide (MenB CP) as a vaccine is hampered by t...
Previous analysis of the class 1 outer-membrane (OM) protein of Neisseria meningitidis has identifie...
A variety of adjuvants with the potential for use with experimental human vaccines were used for imm...
Microbial capsular polysaccharides for many years provided a highly practical public health vaccines...
The antigenic similarity between Neisseria meningitidis group B (NMGB) capsular polysaccharide (PS) ...